335 related articles for article (PubMed ID: 33396647)
1. Immune Modulation by Inhibitors of the HO System.
Fernández-Fierro A; Funes SC; Rios M; Covián C; González J; Kalergis AM
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396647
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms.
Kinobe RT; Vlahakis JZ; Vreman HJ; Stevenson DK; Brien JF; Szarek WA; Nakatsu K
Br J Pharmacol; 2006 Feb; 147(3):307-15. PubMed ID: 16331285
[TBL] [Abstract][Full Text] [Related]
3. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors.
Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
J Med Chem; 2006 Jul; 49(14):4437-41. PubMed ID: 16821802
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of novel imidazole-dioxolane heme oxygenase inhibitors in renal proximal tubule epithelial cells.
Kinobe RT; Ji Y; Vlahakis JZ; Motterlini R; Brien JF; Szarek WA; Nakatsu K
J Pharmacol Exp Ther; 2007 Dec; 323(3):763-70. PubMed ID: 17761847
[TBL] [Abstract][Full Text] [Related]
5. X-ray crystallographic and biochemical characterization of the inhibitory action of an imidazole-dioxolane compound on heme oxygenase.
Sugishima M; Higashimoto Y; Oishi T; Takahashi H; Sakamoto H; Noguchi M; Fukuyama K
Biochemistry; 2007 Feb; 46(7):1860-7. PubMed ID: 17253780
[TBL] [Abstract][Full Text] [Related]
6. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
[TBL] [Abstract][Full Text] [Related]
7. A focus on heme oxygenase-1 (HO-1) inhibitors.
Pittalà V; Salerno L; Romeo G; Modica MN; Siracusa MA
Curr Med Chem; 2013; 20(30):3711-32. PubMed ID: 23746277
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of the heme oxygenase - carbon monoxide system: on the doorstep of the clinic?
Kinobe RT; Dercho RA; Nakatsu K
Can J Physiol Pharmacol; 2008 Sep; 86(9):577-99. PubMed ID: 18758507
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.
Mucha O; Podkalicka P; Mikulski M; Barwacz S; Andrysiak K; Biela A; Mieczkowski M; Kachamakova-Trojanowska N; Ryszawy D; Białas A; Szelążek B; Grudnik P; Majewska E; Michalik K; Jakubiec K; Bień M; Witkowska N; Gluza K; Ekonomiuk D; Sitarz K; Gałęzowski M; Brzózka K; Dubin G; Józkowicz A; Dulak J; Łoboda A
Arch Biochem Biophys; 2019 Aug; 671():130-142. PubMed ID: 31276659
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
Bioorg Med Chem; 2013 Nov; 21(21):6788-95. PubMed ID: 24021581
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring.
Vlahakis JZ; Hum M; Rahman MN; Jia Z; Nakatsu K; Szarek WA
Bioorg Med Chem; 2009 Mar; 17(6):2461-75. PubMed ID: 19268600
[TBL] [Abstract][Full Text] [Related]
12. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
Salerno L; Floresta G; Ciaffaglione V; Gentile D; Margani F; Turnaturi R; Rescifina A; Pittalà V
Eur J Med Chem; 2019 Apr; 167():439-453. PubMed ID: 30784878
[TBL] [Abstract][Full Text] [Related]
13. In vivo inhibition of renal heme oxygenase with an imidazole-dioxolane inhibitor.
Csongradi E; Vera T; Rimoldi JM; Gadepalli RS; Stec DE
Pharmacol Res; 2010 Jun; 61(6):525-30. PubMed ID: 20338241
[TBL] [Abstract][Full Text] [Related]
14. Recombinant truncated and microsomal heme oxygenase-1 and -2: differential sensitivity to inhibitors.
Vukomanovic D; McLaughlin B; Rahman MN; Vlahakis JZ; Roman G; Dercho RA; Kinobe RT; Hum M; Brien JF; Jia Z; Szarek WA; Nakatsu K
Can J Physiol Pharmacol; 2010 Apr; 88(4):480-6. PubMed ID: 20555417
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent
Fallica AN; Sorrenti V; D'Amico AG; Salerno L; Romeo G; Intagliata S; Consoli V; Floresta G; Rescifina A; D'Agata V; Vanella L; Pittalà V
J Med Chem; 2021 Sep; 64(18):13373-13393. PubMed ID: 34472337
[TBL] [Abstract][Full Text] [Related]
16. Heme oxygenase and renal disease.
Jarmi T; Agarwal A
Curr Hypertens Rep; 2009 Feb; 11(1):56-62. PubMed ID: 19146802
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase inhibition by 1-aryl-2-(1h-imidazol-1-yl/1h-1,2,4-triazol-1-yl)ethanones and their derivatives.
Roman G; Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
ChemMedChem; 2010 Sep; 5(9):1541-55. PubMed ID: 20652928
[TBL] [Abstract][Full Text] [Related]
18. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation.
Ryter SW; Choi AM
Transl Res; 2016 Jan; 167(1):7-34. PubMed ID: 26166253
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.
Salerno L; Pittalà V; Romeo G; Modica MN; Siracusa MA; Di Giacomo C; Acquaviva R; Barbagallo I; Tibullo D; Sorrenti V
Bioorg Med Chem; 2013 Sep; 21(17):5145-53. PubMed ID: 23867390
[TBL] [Abstract][Full Text] [Related]
20. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells.
Dulak J; Józkowicz A; Foresti R; Kasza A; Frick M; Huk I; Green CJ; Pachinger O; Weidinger F; Motterlini R
Antioxid Redox Signal; 2002 Apr; 4(2):229-40. PubMed ID: 12006174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]